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Abstract 
 Telomeres are maintained by three DNA binding proteins, TRF1, TRF2 
and POT1, and several associated factors.  One factor, TIN2, binds TRF1 and 
TRF2 directly and POT1 indirectly.  These and two other proteins form a soluble 
complex that may be the core telomere-maintenance complex.  It is not clear 
whether subcomplexes exist or function in vivo.  Here, we provide evidence for 
two TIN2 subcomplexes with distinct functions in human cells.  TIN2 ablation by 
RNA interference caused telomere uncapping and p53-independent cell death in 
all cells tested.  However, we isolated two TIN2 complexes from cell lysates, 
each selectively sensitive to a TIN2 mutant (TIN2-13, TIN2-15C).  In cells with 
wild-type p53 function, TIN2-15C was more potent than TIN2-13 in causing 
telomere uncapping and eventual growth arrest.  In cells lacking p53 function, 
TIN215C more than TIN2-13 caused genomic instability and cell death.  Thus, 
TIN2 subcomplexes likely have distinct functions in telomere maintenance, and 
may provide selective targets for eliminating cells with mutant p53.   
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 Telomeres are the repetitive DNA sequence and specialized proteins that 
cap the ends of linear eukaryotic chromosomes and protect them from 
degradation or fusion by DNA repair processes.  Telomere integrity and length 
maintenance are essential for prolonged cell proliferation and are thought to play 
important roles in suppressing aging and cancer1,2.    
 
 Telomere length is generally maintained by telomerase, a reverse 
transcriptase that adds telomeric DNA repeats to chromosome ends.  Telomere 
length homeostasis also depends on proteins that act in cis at the telomeres to 
control telomerase recruitment or access3.  Most human cells do not express 
telomerase.  Because DNA replication machineries cannot fully copy DNA 3’ 
ends, such cells lose 50-200 bp of telomeric DNA with each S phase and enter a 
permanent growth arrested state termed senescence when telomeres become 
critically short1.  Both telomerase-expressing and telomerase-negative cells 
utilize and require a host of proteins to ensure a proper protective telomeric 
structure.   
 
 The precise structure of mammalian telomeres is not known.  However, a 
‘t-loop’ structure, in which the 3’ overhang loops back on the double stranded 
telomeric DNA and invades the duplex, has been inferred by electron microscopy 
and biochemical experiments4.  The t-loop model explains how the telomeric 
ends are protected from recognition by DNA repair machineries.  This protection 
is sometimes termed capping.   Telomeres can lose capping when they become 
critically short, presumably too short to form a t-loop, or when telomeric proteins 
that participate in telomere capping are defective.   
 
Several telomere-associated proteins are known to be important for 
telomere length regulation and capping1,3,5.  These include the direct telomeric 
DNA binding proteins TRF1, TRF2, and POT1, proteins that associate with these 
telomeric DNA binding actors (e.g., TIN2, RAP1, tankyrases), and a variety of 
proteins involved in other processes, such as DNA repair and recombination.  Of 
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the direct DNA binding proteins, TRF1 binds double stranded telomeric DNA and 
is an important regulator of telomere length6.  In contrast, TRF2, which also binds 
double stranded telomeric DNA, is more important for telomere capping7-9 and t-
loop formation10.  POT1 binds the single-stranded 3’ overhang and is likely a 
terminal regulator of telomere length and end protection11. 
 
TIN2 is an important telomere-associated protein because it binds both 
TRF112 and TRF213,14,15, and indirectly interacts with POT1 via the intermediary 
protein TPP1, also termed pTOP16, PIP117, and TINT118.  TIN2 participates in the 
regulation of telomere length through its interactions with TRF112 and TPP116,17, 
18.  In addition, TIN2 appears to be a critical component in forming telomere 
complexes that function in end-protection13.   
 
The functions of the three telomeric DNA binding proteins (TRF1, TRF2 
and POT1) are very likely coordinated.  Perturbations to either TRF1 or TRF2, or 
their associated proteins POT1, RAP1 or TIN2, influence both telomere length 
and capping6,11-13,19-22.  These observations suggest that TRF1, TRF2, POT1, 
and TIN2 may function in the same pathway.  Consistent with this idea, six 
proteins co-purified in a large molecular weight complex14,15,23.  This complex 
may be the core molecular machinery that regulates mammalian telomeres.  On 
the other hand, gel filtration identified a TRF2-RAP1 complex that also contains 
TIN2 and POT1 but not TRF114.  Further, when TRF1 is removed from 
telomeres, TIN2 and TPP1 remain at telomeres via increased association with 
TRF218.  And, although POT1 was shown to be associated with TRF119, POT1 
and TRF2 also form a complex with telomeric DNA, and POT1 overexpression 
protects against loss of telomeric single-stranded DNA caused by expression of a 
dominant negative TRF2 (DN-TRF2)22.  Thus, there may be distinct telomeric 
complexes that participate in maintaining telomere length and capping. 
 
It is not yet clear whether there is a single TIN2 complex, which always 
contains TRF1, TRF2 and TPP1/POT1 and their interacting proteins, or whether 
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TIN2 forms multiple complexes, some of which contain TRF1, while others 
contain TRF213,14,18.  Further, although it is hypothesized that telomeric 
complexes respond to telomere shortening, it is not known which telomere 
complexes are important for telomere capping, cellular senescence and cell 
death.   Here, we report that at least two major TIN2-complexes can be identified 
by immunoprecipitation of cell lysates, and that one of these is crucial for cellular 
senescence and p53-independent cell survival.   
 
Results   
 
TIN2 depletion disrupts both TRF1 and TRF2 and causes p53-independent 
cell death 
To understand the effects of TIN2 on cell fate and telomeric complex 
integrity, we used RNA interference (RNAi) to ablate TIN2 expression.  Short 
hairpin (sh) RNAs24 complementary to three regions of the TIN2 mRNA (T2i-1, 
T2i-2, T2i-3) were expressed in HT1080 human fibrosarcoma cells.  Two of these 
shRNAs, T2i-2 and T2i-3, reduced TIN2 protein levels by 80-90% (Fig. 1a).  T2i-2 
and T2i-3 (not shown) also reduced TRF1 and TRF2 protein levels (Fig. 1b), 
consistent with their reported degradation upon removal from telomeres25, and 
T2i-2 reduced focal immunostaining, indicative of telomeric localization, of all 
three proteins (TIN2, TRF1, and TRF2) (Fig. 1c).  Thus, loss of TIN2 completely 
disrupted telomeres, as determined by loss of TRF1 and TRF2 protein levels and 
telomeric occupancy.   
 
Following the loss of telomeric TIN2, TRF1 and TRF2, T2i-2 and T2i-3 
induced caspase-dependent cell death, indicative of apoptosis (Fig. 1d).  Cell 
death was not observed when cells expressed an insertless vector, a non-
specific shRNA or T2i-1, which did not reduce TIN2 expression (Figs. 1a and d).  
T2i-2 also induced apoptosis (Fig. 1e) in primary human fibroblasts (strains 
HCA2 and WI-38).  Strikingly, inactivation of p53 by expression of GSE-22, a 
short peptide that disrupts p53 tetramerization in these cells26 failed to rescue 
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WI-38 cells from undergoing T2i-2-induced apoptosis (Fig 1e).  The loss of p53 
activity was confirmed by the absence of detectable p21 immunostaining in GSE-
expressing, but not control, cells (Fig. 1f).  Thus, TIN2 was essential for TRF1 
and TRF2 stability and occupancy at telomeres, as well as the viability of normal 
and tumor-derived human cells, regardless of p53 status.  This result suggests 
that loss of TIN2 promotes a seriously aberrant telomeric structure that induces 
p53-independent cell death, similar to the effects of complete telomere disruption 
caused by expression of a mutant telomerase template RNA27.   
 
Two major TIN2-complexes are formed in cells 
TIN2-13 and TIN3-15C are TIN2 truncation mutants with different binding 
capabilities for TRF1 and TRF2 (Fig. 2a).  TIN2-15C retains the TRF213 and 
TPP1/POT1 (Fig. 2b) binding domains, but lacks TRF1 binding12,16.  TIN215C 
interacts less strongly than wild-type TIN2 with TRF2, as determined by 
immunoprecipitation and yeast two-hybrid analyses13, suggesting additional TIN2 
domains are needed for tight TRF2 binding.  By contrast, TIN2-13 is a C-terminal 
TIN2 fragment that retains TRF1 binding12, but lacks TRF213 and TPP1/POT117 
binding.   
 
We used these TIN2 mutants to identify TIN2 complexes in cells, and 
determine their role in the p53-independent cell death caused by complete loss 
of TIN2.  We overexpressed epitope-tagged POT1, TIN2 or TRF1 (V5-tagged 
POT1, Flag-TIN2, HA-tagged TRF1) in HT1080 cells and used epitope-tag 
immunoprecipitation to isolate complexes from cell lysates.  HA antibodies (Fig. 
2c, lanes 10, 11) precipitated a major TRF1-TIN2 complex and a minor of TRF1-
TIN2-POT1/TRF2 (visible when the gel is overexposed).  These findings suggest 
that most TRF1 proteins form a complex with TIN2, at least under the 
physiological salt conditions used in the immunoprecipitation buffer.  V5-
antibodies precipitated a major POT1-TPP1-TIN2-TRF2 complex, regardless of 
whether TRF1 was overexpressed, and minor TRF1-TIN2-POT1-TRF2 and 
TRF1-TIN2-POT1 complexes (overexposed inset).  Because POT1 does not 
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interact directly with TRF119, and interacts with TRF222 and TPP116,17,18, this 
result suggests that POT1 forms a more stable complex with TIN2-TRF2 than 
with TIN2-TRF1.  FLAG antibodies (lanes 6, 7) precipitated a TIN2-TRF2-POT1 
complex in the absence of overexpressed TRF1; TRF1 overexpression reduced 
formation of this complex and favored the formation of a TRF1-TIN2 complex.  
These results confirm that TRF1 and TRF2 compete with TIN2 to form separable 
complexes13,14,18.  For simplicity, we term these complexes as follows: TRF1-
TIN2, TIN2 complex A; TIN2-TRF2-POT1, TIN2 complex B; TRF1-TIN2-POT1-
TRF2, combined complex C (Fig. 2d).   
 
TIN2 mutants have distinct effect on TIN2-complexes. 
We tested the effects of the TIN2 mutants on the formation of complexes 
A, B and C.  Based on the complexes we identified (Fig. 2d), we predicted that 
TIN2-13, which lacks TPP1 and TRF2 binding16,17 , would perturb complexes A 
and C, whereas TIN2-15C, which lacks TRF1 binding, would perturb complexes 
B and C.   
 
We expressed V5-POT1 plus TIN2 (wild-type), TIN2-13 or TIN2-15C in 
HT1080 cells, and immunoprecipitated cell lysates using V5 antibodies (Fig. 3a, 
lanes 5-8).  When TIN2-13 was expressed, V5 antibodies did not precipitate 
TIN2-13, and the presence of TIN2-13 did not alter the level of endogenous TIN2 
in the precipitate (compare lanes 6 and 7).  This result indicates that V5-POT1 
mainly precipitated TIN2 B complexes, and that TIN2-13 does not disrupt B 
complexes, as predicted.  This result also confirms the inability of TIN2-13 to 
interact with TRF213 and POT117.   
 
By contrast, when TIN2-15C was expressed, V5 antibodies precipitated 
TIN2-15C, and the presence of TIN2-15C reduced the level of endogenous TIN2 
in the precipitate (lane 8).  This result suggests that TIN2-15 disrupted complex B 
formation, as predicted, and is consistent with the finding that TIN2-15C reduces 
TRF2 stability in cells and dissociates TRF2 from telomeres13.   
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We also expressed HA-TRF1 plus wild-type TIN2, TIN2-13 or TIN2-15C, 
and immunoprecipitated cell lysates using HA antibodies (Fig. 3b, lanes 13-16).  
Expression of TIN2-13 reduced the binding of endogenous TIN2 to HA-TRF1 
(compare lanes 13 and 15), but expression of TIN2-15C did not disrupt this 
interaction (compare lanes 13 and 16).  Thus, as predicted, TIN2-13 disrupted 
TIN2-TRF1 complexes (complex A), but expression of TIN2-15C did not.   
 
We conclude that the TIN2 mutants TIN2-13 and TIN2-15C disrupt 
different TIN2 complexes, at least by immunoprecipitation analysis, and thus 
favor the formation of different telomeric complexes when expressed in cells.   
 
Effects of TIN2 mutants in cells 
To determine the biological effects of the TIN2 complexes, we expressed 
GFP (control), TIN2-13 or TIN2-15C in primary human fibroblasts (strain HCA2).  
We first tested presenescent (P) or replicatively senescent (S) cells, with or 
without p53 inactivation by GSE-22, and measured apoptotic cell death using a 
sensitive cumulative assay28 (Fig. 4a).  In contrast to the robust cell death caused 
by complete loss of TIN2 (Fig. 1d,e), TIN-13 or TIN2-15C caused little or no cell 
death when expressed in presenescent or senescent cells with normal p53 
function (Fig. 4a).  However, when p53 was inactivated, the fraction of apoptotic 
cells increased in both cell populations (Fig. 4a).  Notably, co-expression of TIN2-
13 and GSE-22 elevated apoptosis only about 2-fold above control levels 
(caused by GFP and GSE-22), whereas co-expression of TIN2-15C and GSE-22 
increased cell death 8-10 fold (Fig. 4a).  These findings suggest that disruption of 
telomeric complexes B and C (by TIN-15C) had more severe consequences for 
cell survival than disruption of complex A (by TIN2-13), and that the cell death 
caused by disrupting these complexes is p53-independent.   
 
Late generation mice lacking both telomerase and p53 progress very few 
additional generations relative to telomerase deficiency alone, suggesting the 
existence of a telomere-dependent, p53-independent cell death pathway29.  To 
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further test the idea that disruption of different telomeric complexes differentially 
affects p53-independent cell survival, we used lenti-viral vectors to express TIN2 
mutants and GSE-22 in senescent HCA2 fibroblasts, which have several short 
dysfunction telomeres30, similar to those in late generation telomerase-deficient 
mice31.  Because HCA2 cells express low levels of p16 (not shown), which 
inhibits the proliferation of cells that lack p53 function, p53 inactivation causes 
senescent HCA2 cells to resume proliferation, as reported for other low p16-
expressing primary human fibroblasts32.  We therefore measured the ability of 
senescent HCA2 cells to form colonies following p53 inactivation by GSE-22 and 
disruption of telomere complexes by TIN2 mutants or a dominant-negative TRF2 
protein (DN-TRF2) that was shown to uncap telomeres and induce p53-
dependent cell death9 (Fig. 4b).  Senescent cells readily formed colonies upon 
expression of GSE-22, as expected32.  Subsequent expression of GFP (control), 
TIN2-13, or DN-TRF2 had no effect on colony formation over >30 days.  By 
contrast, subsequent expression of TIN2-15C initially had no effect on cell 
proliferation (for 3-10 days; not shown), but then dramatically reduced colony 
formation.  The differences between TIN2-15C and TIN2-13 or DN-TRF2 in 
supporting colony formation could not be explained by differences in protein 
expression levels because TIN2-13 and DN-TRF2 were expressed more robustly 
than TIN2-15C (Fig. 4c). 
 
Together, these findings suggest that p53-dependent cell growth requires 
both TIN2 A and B complexes.  By contrast, p53-independent cell growth does 
not require TIN2 A complexes, which are disrupted by TIN2-13 (Fig. 3), but does 
require TIN2 B complexes, which are disrupted by TIN2-15C (Fig. 3).  DN-TRF2, 
which lacks the TRF2 DNA binding domain and causes p53-dependent cell 
death9, is clearly not equivalent to TIN-15C in its biological activity, possibly 
because it does not affect POT1 function in B complexes (see Discussion).  
 
We confirmed the selective sensitivity of p53-deficient cells to TIN2-15C 
using several human cancer cell lines.  These included HT1080 fibrosarcoma 
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cells (which were reported to undergo no cell death upon expression of DN-
TRF29), MDA-MB-231 and MDA-MB-157 breast cancer cells, and PPC-1 
prostate cancer cells.  We used a transfected pIRES2-eGFP vector13, and 
measured apoptotic cell death.  TIN2-15C expression induced significant cell 
death within 48 h in all these p53-deficient cancer cells (Fig. 4d), whereas TIN2-
13 was 2- to 8-fold less effective, depending on the cell line (Fig. 4d).  Compared 
to normal cells in which p53 was inactivated by GSE-22, apoptosis was more 
robust in the cancer cells, being evident as early as 18 h after transfection, 
presumably because the cancer cells harbor multiple mutations that disrupt cell 
growth and survival pathways.  Nonetheless, in all cases, TIN2-15C, but to a 
lesser extent TIN-13, caused substantial cell death in p53-deficient cells (Fig. 4d), 
but very little cell death in normal cells (Fig. 4a).   
 
Normal cells responded to TIN2-15C by undergoing senescence.  TIN2-
15C, much more than TIN2-13, retarded cell proliferation (Fig. 5a) and induced 
the senescence-associated-β-galactosidase (Fig. 5b).  Both mutants also 
induced 53BP1/γH2AX foci, most of which localized to telomeres13 (and not 
shown), indicating uncapped dysfunctional telomeres33.  The TIN2 mutants 
induced 53BP1 foci in presenescent cells, as well as replicatively senescent cells, 
which already have several telomeric 53BP1 foci.  In all cases, TIN2-15C 
induced many more of these foci than TIN2-13 (Fig. 5c), suggesting that TIN2-
15C is more potent than TIN3-13 at uncapping telomeres.  These results also 
suggest that B complexes are more important than A complexes for protecting 
cells from telomere- and p53-independent cell death.   
 
Chromosomal abnormalities induced by TIN2 mutants 
Although p53-deficient cancer cell lines underwent rapid cell death in 
response to TIN-15C, p53 inactivation and TIN2-15C expression did not cause 
rapid cell death in presenescent or senescent human fibroblasts (in contrast to 
the effect of TIN2 depletion).  Thus, additional events, such as cell cycle 
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progression and subsequent chromosome fusion, might be necessary for the 
death of cells with minimal lesions that inactivate p53 and complex B functions.   
 
To test this possibility, we expressed GFP (control), TIN2-13 or TIN2-15C 
in HCA2 cells in which p53 was inactivated by GSE-22.  Cells expressing TIN2-
15C had a significantly higher number of chromosome fusions, compared to cells 
expressing TIN2-13 (Table 1).  We observed no chromosome fusions in cells 
expressing GFP.  The level of chromosome fusions in cells expressing TIN2-15C 
was similar to that reported for cells expressing DN-TRF27,22,34, consistent with 
the finding that expression of TIN2-15C reduces TRF2 at telomeres13.  Thus, 
TIN2-15C may cause the death of p53-deficient cells with no other genetic 
lesions by indirectly driving chromosome fusions, breakage and mitotic 
catastrophe.   
 
Telomerase does not rescue TIN2-15C lethality 
TIN2-15C may cause chromosome fusions by accelerating telomere 
shortening.  To test this idea, we co-expressed the telomerase catalytic subunit 
(hTERT) and TIN2-15C in senescent HCA2 cells in which p53 was inactivated by 
GSE-22.  Expression of telomerase in p53-inactivated senescent cells prevented 
the crisis that limits the proliferative capacity of these cells to approximately 20 
population doublings32.  However, co-expression of telomerase and TIN2-15C did 
not rescue the cells from loss of proliferative potential (Fig. 6a,b).  This result 
suggests that expression of TIN2-15C in p53-deficient senescent cells does not 
induce cell death by accelerating telomere shortening.  Rather, the results 
suggest that TIN2-15C causes cell death by disrupting telomeric structure and 
capping.   
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Discussion 
 
TIN2 telomeric complexes. 
Six telomere-associated proteins (TRF1-TIN2-TPP1-POT1-TRF2-hRAP1) 
have been isolated as a single soluble complex14,15.  TIN2 occupies a unique 
position in this complex because it interacts directly with TRF1 and TRF2, and 
indirectly (through TPP1) with POT1.  In these studies, TRF2-complexes 
contained TIN2 and POT1, but not TRF1, suggesting that TRF1 is not required 
for the TRF2-TIN2-TPP1-POT1 interaction18.  TRF1 and TRF2 bind non-
cooperatively along arrays of telomere repeats and have high off-rates in vitro35 
and in vivo36.  These results suggest that TIN2 may form dynamic TRF1 or 
TRF2-POT1 complexes at telomeres.  We identified two major soluble 
complexes (TRF1-TIN2, complex A, and TIN2-TRF2-POT1, complex B), in 
addition to a single minor complex, supporting the idea that TRF1 and TRF2 
complexes are separable.   
 
We utilized two TIN2 mutants with distinct abilities to disrupt the major 
TIN2 complexes (A and B).  The N-terminal deletion mutant TIN2-13 affected the 
TRF1-TIN2 complex A, whereas the C-terminal deletion mutant TIN2-15C 
affected TRF2-complexes.  If the major telomeric complex were a single entity 
(complex C), TIN2-13 and TIN2-15C should disrupt this complex similarly.  
However, our results are more consistent with the existence of two separable 
complexes, which may have different functions in cells. 
 
TIN2 complexes may function differently.    
In normal cells, telomeres shorten with each division, resulting eventually 
in replicative senescence.  TIN2-15C, which we show here disrupts B complexes, 
removes TRF2 from telomeres and induces DNA damage foci, but does not 
reduce TRF1 at telomeres13.  Expression of DN-TRF2 also removes TRF2, with 
DNA damage foci co-localizing with TRF133.  Senescent cells with short 
telomeres and telomeric DNA damage foci frequently lack TRF2 but not TRF137.   
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Therefore, it is possible that short telomeres preferentially attract A complexes, 
and that senescent cells cannot form enough B (TIN2-TRF2-POT1) complexes 
because TIN2 is bound primarily in A (TRF1-TIN2) complexes.  Alternatively, A 
and B complexes may have different preferred locations along the telomeric DNA 
and at the t-loop, and may cooperate in telomere capping.  Short telomeres may 
preferentially lose B complexes owing to their location, for example enrichment at 
or near t-loops. 
 
TRF1-TIN2 complexes stimulate interactions between telomeric DNA 
tracts in vitro, suggesting that this complex modulates a tertiary telomeric 
structure38.  Thus, TIN2-13, which disrupts this complex (A complex), may 
decrease the complexity of the telomeric structure.  On the other hand, deletion 
of TRF2 or POT1 causes telomere uncapping and chromosome end-to-end 
fusions, suggesting that the B complex is essential for telomere end 
protection39,40.  Consistent with this view, we found that TIN2-15C, which disrupts 
B complexes, uncapped telomeres, evident as telomeric DNA damage foci, and 
caused telomeric fusions.  Thus, we propose that TRF1-TIN2 (A) complexes and 
TIN2-TRF2-TPP1/POT1 (B) complexes have different locations at telomeres and 
cooperate to form the telomeric cap (Fig. 6c).  B complexes are more important 
for ensuring a proper terminal or t-loop structure, whereas A complexes modulate 
the telomeric tertiary structure and enhance the stability and function of B 
complexes.  Although TIN2-13 induces some telomere uncapping and telomeric 
fusions, the effects of TIN2-13 are less pronounced than those of TIN2-15C, 
suggesting that A complexes support the functions of B complexes.   
 
As an alternative model, A and B complexes may cooperate to form the 
six protein complex (C complex), and this complex may be the essential entity for 
telomere capping.  TIN2-13 may be less efficient than TIN2-15C at disrupting C 
complexes.   TPP1 may be an important regulator of C complex formation 
because loss of TPP1 can reduce the TRF1-TRF2-Rap1 interaction 23.   
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Telomere-dependent, p53-independent cell survival. 
Late generation mice lacking both telomerase and p53 have a higher 
incidence of cancer relative to animals lacking only telomerase29,41 defining p53 
as a key regulator of the response to telomere dysfunction.  However, mice 
deficient in both p53 and telomerase lose sterility after only a few generations, 
defining a second p53-independent block to cell viability29.   Expression of 
dominant-negative telomerase proteins42 or mutant telomerase RNAs43 induces 
death in cells with either wild type or mutant p53, supporting the idea that loss of 
viability caused by telomere dysfunction is not dependent on a functional p53 
response.  By contrast, cell death or growth inhibition due to expression of DN-
TRF2 is p53-dependent8,9.  Our results indicate that B complex disruption by 
TIN2-15C causes p53-independent cell death, suggesting that DN-TRF2 and 
TIN2-15C have different effects on the integrity of this complex.   
 
In the absence of p53 activity, senescent cells that express little or no p16 
can resume growth, although their proliferative potential is eventually limited by 
severe telomere shortening, crisis and massive cell death32.  Expression of 
telomerase eliminated this growth limitation.  Expression of TIN2-13 and DN-
TRF2 only minimally affected this p53-independent growth resumption, whereas 
TIN2-15C expression accelerated this growth limitation.  Recent findings34,39,40  
suggest an explanation for why the effects of TIN2-15C differ from those of DN-
TRF2.  Although, POT1deficiency causes a telomere uncapping phenotype 
similar to that caused by TRF2 loss, POT1 and TRF2 likely have distinct 
functions in protecting telomeres, regulating nucleolytic processing and 
controlling recombination at telomeres.  Thus, TIN2-15C and DN-TRF2 likely 
inactivate TRF2 and POT1 differently in B complexes.  Since DN-TRF2 induces 
p53-dependent apoptosis9, whereas TIN2-15C caused p53-independent cell 
death, our findings offer an explanation for why ablation of TIN2 in cells (Fig. 1), 
and in the mouse germ line44, causes cell lethality or senescence, regardless of 
p53 status.   
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It remains to be understood how telomere dysfunction causes p53-
independent cell death, how dysfunctional telomeres are sensed as DNA 
damage, and nature of the p53-dependent and p53-independent sensing 
mechanisms.  Despite these gaps in our knowledge, telomerase inactivation has 
been proposed as an anti-cancer strategy because most cancer cells maintain 
telomere length by expressing this enzyme.  Likewise, disruption of TIN2-
complexes may provide a strategy for killing cancer cells, most of which lack p53 
function.  TIN2-15C induced cell death in p53-inactivated cancer cells, but 
induced growth arrest in p53 positive normal cells.  Therefore, TIN2-15C 
sensitive complexes are more critical for cell survival in p53-negative cancer cells, 
compared to normal cells. 
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Experimental Procedures: 
 
Cell culture, senescence and apoptosis characterization: We cultured all 
cells, and measured senescence-associated β-galactosidase, as described45 .  
We determined cell death by collapse of the mitochondrial membrane potential46 
or by a sensitive cumulative assay in which cells are incubated with a caspase 
inhibitor for 3 days and scored for cytosolic cytochrome c28.   
 
Purification of TIN2 complexes: We expressed FLAG-tagged TIN2 and HA-
tagged TRF1 in HT1080 cells using the retroviral vector pLXSN, as described12.  
V5-tagged POT147 and myc-TIN2 mutants (TIN2-13 or TIN2-15C) were 
expressed using the pIRE2-EGFP vector (Bio Science) and transient transfection 
using Fugene 6 (Roche).  Cells (6 x 106) were washed with phosphate buffered 
saline (PBS), and 1 ml RIPA buffer {50 mM Tris, pH 7.5, 150 mM NaCl, 1% NP-
40, 1 mM EDTA, 10% glycerol, protease inhibitor cocktail (Roche)} was added to 
each plate.  After incubation on ice for 30 min, cells were collected by scraping 
and centrifugation at 4° C, and the supernatant (cell lysate) was recovered. 
 
Immunoprecipitation and western analyses: We incubated cell lysates (200-
300 µg protein) with 2 µg HA antibody (Roche), 10 µg FLAG M2 antibody (Sigma) 
or 2 µg V5 antibody (Invitrogen) for 2 h at 4˚ C, and added 50 µl of a 50 % 
protein A-Sepharose slurry (Pharmacia) for 2 h at 4˚ C.  We washed the immune 
complexes with RIPA buffer and analyzed proteins by western blotting as 
described12,46.  Primary antibodies were anti-TRF2 mouse monoclonals 
(Imgenex), rabbit polyclonal anti-HA- or -TRF2 or monoclonal anti-HA (Santa 
Cruz), monoclonal anti-V5 (Invitrogen), and polyclonal anti-TIN212.   
 
Immunostaining:  We immunostained cells as described12.  Briefly, we cultured 
cells in chamber slides, fixed with 4% formalin, permeabilized with 0.5% Triton-
X100, and stained with mouse anti-TRF2 (Imgenex), polyclonal anti-TIN212, 
polyclonal anti-53BP1 (Abcam), mouse anti-p21 (Pharmigen) or control 10% goat 
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serum (Vector).  After washing, we stained with secondary antibodies conjugated 
to Texas Red or FITC (Molecular probes), and counterstained the nuclei with 
DAPI.   
 
Chromosome analyses:  Telomeres were visualized by in situ hybridization 
(FISH) on metaphase spreads using a telomeric protein nucleic acid (PNA) probe, 
as described48.   Cells treated with colcemid (0.1µg/ml) for 4 h were trypsinized 
and collected at 1000 X g (5 min).  After hypotonic swelling in 30 mM Na citrate 
for 20 min at 37o C, the cells were fixed in methanol:acetic acid (3:1). FISH using 
a Cy3-labeled (CCCTAA)3 peptide nucleic acid (PNA) probe (Applied Biosystem) 
and scoring for telomeric fusions  were performed as described49.    
 
shRNA and expression vectors:  Where indicated, cells were infected with a 
retrovirus expressing GSE-2226, selected and then transfected with expression 
vectors or infected with lenti-viruses, as described13,32.  To ablate TIN2 
expression, we synthesized double stranded DNAs to target the TIN2 mRNA 
(T2i-1:caggtgaagcagctgtcag; T2i-2: ggtcatatctaatcctgag, T2i-3: 
gtggtggtggagctgatc) or SATB1, a nuclear protein that is not expressed in 
fibroblasts or HT1080 cells (N/S (non-specific): aacagctactattgccact).  We cloned 
the DNA into the pSuper vector24, and transiently transfected packaging cells 
using FuGene6 (Roche).  We cloned TIN2 mutants into the bicistronic pIRES2-
EGFP (Clontech) or pPRL-Sin18-lenti vector50.  Lentiviruses were used at 
equivalent titers, sufficient to infect approximately 80-90% of cells. 
 
Colony formation assay:  Senescent cells (less than 2% labeling index) were 
plated with 5 X 104 cells in 6 well plates and infected with lentiviruses expressing 
GFP, TIN2-15C, TIN2-13, hTERT or GSE-22 as described32.  The cells were 
washed with PBS twice, fixed and stained with 0.1 % crystal violet in 10% 
ethanol for 5 min at room temperature, washed with PBS and dried. 
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Figure Legends  
 
FIGURE 1.  Effects of TIN2 ablation on TRF1, TRF2 and cell viability.   
a.  RNAi reduces TIN2 expression.  HT1080 cells were transiently transfected 
with pSuper vectors expressing shRNAs corresponding to a non-expressed 
(non-specific, N/S) mRNA or one of three distinct regions in the TIN2 mRNA 
(T2i-1, T2i-2, T2i-3), as described in Methods.  Transfection efficiency varied 
from 60-80%.  Cell lysates were analyzed 48 h later by western blotting for 
TIN2 expression, with tubulin used as a loading control.  
b.  TIN2 reduction decreases TRF1 and TRF2 protein expression.  Lysates 
from HT1080 cells transfected with the N/S (control) or T2i-2 pSuper vectors 
described above were analyzed for TIN2, TRF1, TRF2 and tubulin by western 
blotting.   
 c.  TIN2 reduction decreases TRF1 and TRF2 foci .  HT1080 cells transfected 
with the N/S (control) or T2i-2 pSuper vectors described above were 
immunostained for TIN2 and TRF1 (left panels) or TRF2 (right panels).  
Arrowheads indicate nuclei (visible by DAPI) that lack TIN2 and TRF1 (left 
panels) or TRF2 (right panels) immunostaining.   
d.  TIN2 reduction induces apoptosis in human tumor cells.  HT1080 cells 
were transiently transfected with pSuper vectors containing no insert (Vector) 
or N/S (control), T2i-1, T2i-2, or T2i-3 shRNAs and analyzed 48 h later for 
apoptosis as described in Methods.  Transfection efficiency was 60-80%.  
Where indicated, the caspase inhibitor ZVAD (100 µM) was added 8 h after 
transfection.  200 cells were analyzed for apoptosis in three independent 
experiments.   
e.  TIN2 reduction induces apoptosis in normal human cells.  Normal human 
fibroblasts (HCA2 and WI-38) were transiently co-transfected with pSuper 
vectors containing no insert (Vector) or T2i-1 or T2i-2 shRNAs, and a lenti-
GFP vector at a ratio of 10:1.  48 h later, GFP positive cells were analyzed for 
apoptosis as described in Methods.  Where indicated, WI-38 cells were first 
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infected with a retrovirus expressing GSE-22, selected and then infected with 
the pSuper and GFP vectors.  200 cells were analyzed in three experiments. 
f.  GSE-22 inactivates p53 activity in normal cells. 
 WI38 cells were infected with a retrovirus expressing GSE-22 or insertless 
virus, selected, plated and then irradiated with 10 Gy X-ray.  The cells were 
fixed 19 hrs later and immunostained for p21.     
 
FIGURE 2.  TIN2-mediated complexes. 
a. TIN2 deletion mutants.  Wild type TIN2 (aa 1-354) showing N-terminal (N-
term), TRF1-interaction (TRF1-Int) and C-terminal (C-term) domains, and 
deletion mutants TIN2-13 (aa 180-354) and TIN2-15C (aa 1-257).    
b. Interaction of TIN2-15C with POT1/TPP1.  Lysates from HT1080 cells that 
transiently expressed Myc-TIN2-15C and V5-POT1 were precipitated using 
anti-Myc or V5 antibodies.  Unprecipitated lysates (10%) and the immune 
precipitates were analyzed for POT1 and TIN2-15C by western blotting (WB).   
c. TIN2-complexes.  We prepared lysates from HT1080 cells that transiently 
expressed V5-tagged POT1 and stably expressed FLAG-TIN2 (lanes 2,4,6,8) 
or HA-TRF1 (1,10) or both Flag-TIN2 and HA-TRF112 (lanes 3,5,7,9,11).  We 
isolated TIN2 complexes using FLAG, V5 and HA antibodies and analyzed 
the lysates (10%, Input) and immunoprecipitates by western blotting (Western) 
for the indicated proteins.  
d. Proposed TIN2 complexes.  A-complex, TIN2-TRF1; B-complex, TIN2-
TRF2-TPP1-POT1; C-complex, TRF1-TIN2-TRF2-TPP1-POT1.  hRAP 
interacts with TRF220, and is presumed to be present in complexes B and C.   
 
FIGURE 3.  TIN2 complexes disrupted by TIN2 mutants 
a. TIN2-TRF2-POT1 complexes disrupted by TIN2-15C, but not TIN2-13.  
Lysates from HT1080 cells transiently expressing WT-TIN2, control vector, 
TIN2-13 or TIN2-15C with V5-POT1 were immunoprecipitated (IP) by anti-V5 
antibody.  The lysates (15%, Input) and immune precipitates were analyzed 
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for TIN2, V5-POT and tubulin by western blotting (WB) (lanes 1-8).  The 
precipitating heavy chain is indicated (IgG). 
b. TRF1-TIN2 complexes disrupted by TIN2-13, but not TIN2-15C.  Lysates 
from HT1080 cells transiently expressing WT-TIN2, vector, TIN2-13 and 
TIN2-15C with HA-TRF1 were immunoprecipitated (IP) by anti-HA antibody.  
The lysates (15%, Input) and precipitates were analyzed for TIN2 and HA-
TRF1 and tubulin by western blotting (WB) (lanes 9-18).  The precipitating 
heavy chain is indicated (IgG).  
 
FIGURE. 4.  Effects ofTIN2 mutants in presenescent and senescent cells.   
a. Cell death caused by TIN2-15C in presenescent cells.  Where indicated, 
presenescent (P) HCA2 cells were first infected with a retrovirus expressing 
GSE-22 and selected for 2-3 days.  Cells were then infected with lentiviruses 
expressing GFP, TIN2-13 or TIN2-15C.  Where indicated, senescent (S) 
HCA2 cells were first infected with lentiviruses expressing GFP, TIN2-13 or 
TIN2-15C, and then infected with a lentivirus expressing GSE-22.  Cells were 
scored for cell death by assessing mitochondrial release of cytochrome c as 
described 28.  300 cells were scored in two or three independent experiments.  
 b.  Effects of TIN2-15C on senescent cells reactivated by GSE-22.  5 x 104 
senescent HCA2 cells were infected with lentiviruses expressing GFP 
(control), TIN2-13, TIN2-15C or DN-TRF2, and then infected with lenti-GSE-
22.  Colonies were stained at the indicated days after infection as described 
in Methods.   
c. Expression levels of TIN2 mutants and DN-TRF2.  Lysates from cells 
presenescent cells infected with the indicated lenti-viruses were analyzed for 
TIN2 and TRF2 by western blotting (WB).  
d. Cell death induced by TIN2-15C in p53-negative cancer cells.  Human 
HT1080 fibrosarcoma, MDA-MB-231 breast cancer, MDA-MB-157 breast 
cancer and PPC-1 prostate cancer cells were transiently transfected with 
pIRES2-eGFP vectors expressing no insert (vector), TIN2-13 or TIN2-15C.  
48 h later, the cells were analyzed for GFP fluorescence, and GFP-positive 
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cells were scored for cell death by collapse of the mitochondrial membrane 
potential as described46.  200 GFP positive cells were scored in two or three 
independent experiments for each transfection. 
 
FIGURE. 5.  Effects of TIN2 mutants in normal cells. 
a. TIN2-15C suppresses proliferation of normal cells.  We infected 
presenescent HCA2 cells with lenti-viruses expressing GFP, wild type (wt) 
TIN2, TIN2-13 or TIN2-15C and determined cell number at the indicated 
number of days thereafter.  Plotted are cumulative cell numbers vs. days in 
culture. 
b. TIN2-15C induces cellular senescence.  HCA2 cells were infected with lenti-
GFP or lenti-TIN2-15C and assessed 10 d later for senescence-associated β-
galactosidase, as described45.  Replicatively senescent HCA2 cells were used 
as positive controls. 
 c.  TIN2-13 and TIN2-15C induces damage foci in presenescent and 
senescent cells.  Presenescent (P) and senescent (S) HCA2 cells were 
infected with lenti-TIN2-13 or lenti-TIN2-15C and stained 48 h later for 
expression of the mutant proteins and γH2AX or 53BP1 foci.  Shown are the 
% cells with varying numbers of foci per nucleus.   
 
FIGURE  6.   
a/b.  Telomerase does not rescue cell death by TIN2-15C.  5 X 104 senescent 
cells were infected with lentiviruses expressing GFP (control), the telomerase 
catalytic subunit hTERT, TIN2-15C or both TIN2-15C and hTERT.  The cells 
were then infected with lenti-GSE-22.  After 2 d, the cells were subcultured 
and plated for colony formation.  Colonies were fixed and stained 61 days 
later.  
b. Colonies were counted 5, 11 and 61 days after plating. 
c.   Proposed model for TIN2 complexes at telomeres. 
Complex A and B cooperate, albeit at different positions on telomeres, to form 
t-loops or other terminal structures.  Complex B may localize preferentially or 
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uniquely near t-loop junctions, whereas A complexes may modulate the 
tertiary structure of telomeres and promote B complex stability.  TIN2-13 
disrupts complex A, thereby reducing the tertiary telomeric structure and 
destabilizing B complexes, resulting in partial or mild disruption of t-loops and 
telomere uncapping.  TIN2-15C directly disrupts B complexes, resulting in 
severe disruption of t-loops and telomere uncapping.  Cells expressing wild 
type p53 and TIN2-13 or TIN2-15 undergo growth arrest, whereas cells 
lacking functional p53 undergo cell death.  In both cases, the consequences 
of TIN2-15C expression are more severe than that of expressing TIN-13.   
 
Table 1. 
  Presenescent HCA2 cells were infected with a retroviruses expressing GSE-
22, selected and then infected with lentiviruses expressing GFP, TIN2-13 or 
TIN2-15C.  The cells were treated with colcemid (0.1µg/ml) for 4 h and 
telomeres of metaphase chromosomes were identified by PNA-FISH, as 
described in Experimental procedures.  
 
TABLE 1. Telomeric fusions caused by expression of TIN2 mutants.  
HCA2 cells 
+ GSE-22 
Metaphases 
analyzed 
(No) 
Cells with 
telomere 
fusions (%) 
Fusions 
/Metaphase 
Fusions 
/Chromosome 
Vector 53 0 0 0 
TIN2-13 53 18.8 0.18 0.0034 
TIN2-15C 61 75.0 0.85 0.0175 
 
 
 
 
 
Kim et al.  Page 23 of 25 
References: 
 
1. Rodier, F., Kim, S. H., Nijjar, T., Yaswen, P. & Campisi, J. Cancer and aging: 
the importance of telomeres in genome maintenance. Int J Biochem Cell Biol 
37, 977-90 (2005). 
2. Blackburn, E. H. Telomere states and cell fates. Nature 408, 53-6 (2000). 
3. Smogorzewska, A. & de Lange, T. Regulation of telomerase by telomeric 
proteins. Annu Rev Biochem 73, 177-208 (2004). 
4. Griffith, J. D. et al. Mammalian telomeres end in a large duplex loop. Cell 97, 
503-14 (1999). 
5. Songyang, Z. & Liu, D. Inside the mammalian telomere interactome: 
regulation and regulatory activities of telomeres. Crit Rev Eukaryot Gene 
Expr 16, 103-18 (2006). 
6. van Steensel, B. & de Lange, T. Control of telomere length by the human 
telomeric protein TRF1. Nature 385, 740-3 (1997). 
7. van Steensel, B., Smogorzewska, A. & de Lange, T. TRF2 protects human 
telomeres from end-to-end fusions. Cell 92, 401-13 (1998). 
8. Smogorzewska, A. & De Lange, T. Different telomere damage signaling 
pathways in human and mouse cells. Embo J 21, 4338-48. (2002). 
9. Karlseder, J., Broccoli, D., Dai, Y., Hardy, S. & de Lange, T. p53- and ATM-
dependent apoptosis induced by telomeres lacking TRF2. Science 283, 1321-5 
(1999). 
10. Stansel, R. M., de Lange, T. & Griffith, J. D. T-loop assembly in vitro 
involves binding of TRF2 near the 3' telomeric overhang. Embo J 20, 5532-40. 
(2001). 
11. Baumann, P. & Cech, T. R. Pot1, the putative telomere end-binding protein 
in fission yeast and humans. Science 292, 1171-5. (2001). 
12. Kim, S. H., Kaminker, P. & Campisi, J. TIN2, a new regulator of telomere 
length in human cells. Nat Genet 23, 405-12 (1999). 
13. Kim, S. H. et al. TIN2 mediates functions of TRF2 at human telomeres. J 
Biol Chem 279, 43799-804 (2004). 
14. Ye, J. Z. et al. TIN2 binds TRF1 and TRF2 simultaneously and stabilizes the 
TRF2 complex on telomeres. J Biol Chem 279, 47264-71 (2004). 
15. Liu, D., O'Connor, M. S., Qin, J. & Songyang, Z. Telosome, a mammalian 
telomere-associated complex formed by multiple telomeric proteins. J Biol 
Chem 279, 51338-42 (2004). 
16. Liu, D. et al. PTOP interacts with POT1 and regulates its localization to 
telomeres. Nat Cell Biol 6, 673-80 (2004). 
17. Ye, J. Z. et al. POT1-interacting protein PIP1: a telomere length regulator 
that recruits POT1 to the TIN2/TRF1 complex. Genes Dev 18, 1649-54 (2004). 
18. Houghtaling, B. R., Cuttonaro, L., Chang, W. & Smith, S. A dynamic 
molecular link between the telomere length regulator TRF1 and the 
chromosome end protector TRF2. Curr Biol 14, 1621-31 (2004). 
19. Loayza, D. & De Lange, T. POT1 as a terminal transducer of TRF1 telomere 
length control. Nature 424, 1013-8 (2003). 
Kim et al.  Page 24 of 25 
20. Li, B., Oestreich, S. & de Lange, T. Identification of human Rap1: 
implications for telomere evolution. Cell 101, 471-83 (2000). 
21. Iwano, T., Tachibana, M., Reth, M. & Shinkai, Y. Importance of TRF1 for 
functional telomere structure. J Biol Chem 279, 1442-8 (2004). 
22. Yang, Q., Zheng, Y. L. & Harris, C. C. POT1 and TRF2 cooperate to 
maintain telomeric integrity. Mol Cell Biol 25, 1070-80 (2005). 
23. O'Connor M, S., Safari, A., Xin, H., Liu, D. & Songyang, Z. A critical role 
for TPP1 and TIN2 interaction in high-order telomeric complex assembly. 
Proc Natl Acad Sci U S A (2006). 
24. Brummelkamp, T. R., Bernards, R. & Agami, R. A system for stable 
expression of short interfering RNAs in mammalian cells. Science 296, 550-3. 
(2002). 
25. Chang, W., Dynek, J. N. & Smith, S. TRF1 is degraded by ubiquitin-
mediated proteolysis after release from telomeres. Genes Dev 17, 1328-33 
(2003). 
26. Gudkov, A. V. et al. Isolation of genetic suppressor elements, inducing 
resistance to topoisomerase II-interactive cytotoxic drugs, from human 
topoisomerase II cDNA. Proc Natl Acad Sci U S A 90, 3231-5. (1993). 
27. Li, S. et al. Rapid inhibition of cancer cell growth induced by lentiviral 
delivery and expression of mutant-template telomerase RNA and anti-
telomerase short-interfering RNA. Cancer Res 64, 4833-40 (2004). 
28. Goldstein, J. C., Rodier, F., Garbe, J. C., Stampfer, M. R. & Campisi, J. 
Caspase-independent cytochrome c release is a sensitive measure of low-level 
apoptosis in cell culture models. Aging Cell 4, 217-22 (2005). 
29. Chin, L. et al. p53 deficiency rescues the adverse effects of telomere loss and 
cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97, 
527-38 (1999). 
30. Zou, Y., Sfeir, A., Gryaznov, S. M., Shay, J. W. & Wright, W. E. Does a 
sentinel or a subset of short telomeres determine replicative senescence? Mol 
Biol Cell 15, 3709-18 (2004). 
31. Hemann, M. T., Strong, M. A., Hao, L. Y. & Greider, C. W. The shortest 
telomere, not average telomere length, is critical for cell viability and 
chromosome stability. Cell 107, 67-77 (2001). 
32. Beausejour, C. M. et al. Reversal of human cellular senescence: roles of the 
p53 and p16 pathways. Embo J 22, 4212-22 (2003). 
33. Takai, H., Smogorzewska, A. & de Lange, T. DNA damage foci at 
dysfunctional telomeres. Curr Biol 13, 1549-56 (2003). 
34. Hockemeyer, D., Sfeir, A. J., Shay, J. W., Wright, W. E. & de Lange, T. 
POT1 protects telomeres from a transient DNA damage response and 
determines how human chromosomes end. Embo J 24, 2667-78 (2005). 
35. Bianchi, A. et al. TRF1 binds a bipartite telomeric site with extreme spatial 
flexibility. Embo J 18, 5735-44 (1999). 
36. Mattern, K. A. et al. Dynamics of protein binding to telomeres in living cells: 
implications for telomere structure and function. Mol Cell Biol 24, 5587-94 
(2004). 
Kim et al.  Page 25 of 25 
37. Herbig, U., Jobling, W. A., Chen, B. P., Chen, D. J. & Sedivy, J. M. Telomere 
shortening triggers senescence of human cells through a pathway involving 
ATM, p53, and p21(CIP1), but not p16(INK4a). Mol Cell 14, 501-13 (2004). 
38. Kim, S. H., Han, S., You, Y. H., Chen, D. J. & Campisi, J. The human 
telomere-associated protein TIN2 stimulates interactions between telomeric 
DNA tracts in vitro. Embo Rep 4, 685-91 (2003). 
39. Wu, L. et al. Pot1 deficiency initiates DNA damage checkpoint activation and 
aberrant homologous recombination at telomeres. Cell 126, 49-62 (2006). 
40. Hockemeyer, D., Daniels, J. P., Takai, H. & de Lange, T. Recent expansion of 
the telomeric complex in rodents: Two distinct POT1 proteins protect mouse 
telomeres. Cell 126, 63-77 (2006). 
41. Artandi, S. E. et al. Telomere dysfunction promotes non-reciprocal 
translocations and epithelial cancers in mice. Nature 406, 641-5 (2000). 
42. Hahn, W. C. et al. Inhibition of telomerase limits the growth of human 
cancer cells. Nat Med 5, 1164-70 (1999). 
43. Guiducci, C., Cerone, M. A. & Bacchetti, S. Expression of mutant telomerase 
in immortal telomerase-negative human cells results in cell cycle 
deregulation, nuclear and chromosomal abnormalities and rapid loss of 
viability. Oncogene 20, 714-25 (2001). 
44. Chiang, Y. J., Kim, S. H., Tessarollo, L., Campisi, J. & Hodes, R. J. 
Telomere-associated protein TIN2 is essential for early embryonic 
development through a telomerase-independent pathway. Mol Cell Biol 24, 
6631-4 (2004). 
45. Dimri, G. P. et al. A biomarker that identifies senescent human cells in 
culture and in aging skin in vivo. Proc Natl Acad Sci U S A 92, 9363-7 (1995). 
46. Davalos, A. R. & Campisi, J. Bloom syndrome cells undergo p53-dependent 
apoptosis and delayed assembly of BRCA1 and NBS1 repair complexes at 
stalled replication forks. J Cell Biol 162, 1197-209 (2003). 
47. Baumann, P., Podell, E. & Cech, T. R. Human Pot1 (protection of telomeres) 
protein: cytolocalization, gene structure, and alternative splicing. Mol Cell 
Biol 22, 8079-87. (2002). 
48. Hultdin, M. et al. Telomere analysis by fluorescence in situ hybridization and 
flow cytometry. Nucleic Acids Res 26, 3651-6 (1998). 
49. Bailey, S. M. et al. DNA double-strand break repair proteins are required to 
cap the ends of mammalian chromosomes. Proc Natl Acad Sci U S A 96, 
14899-904 (1999). 
50. Dull, T. et al. A third-generation lentivirus vector with a conditional 
packaging system. J Virol 72, 8463-71 (1998). 
 
